Barrier Therapeutics, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Barrier Therapeutics, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Barrier Therapeutics, Inc.. The Group's principal activity is the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. Currently it has multiple product candidates in clinical development, with four of these candidates in or entering Phase III clinical trials. Its advanced product candidates are Sebazole, Zimycan, Hyphanox and Liarozole. Its trademarks are Barrier TherapeuticsTM, SebazoleTM, ZimycanTM, HyphanoxTM, RambazoleTM and HivenylTM. The Group operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report